A Randomized, Double-blind, Placebo (PBO) and Positive-Controlled Four-way Crossover Study Assess the Effects of Single Therapeutic and Supratherapeutic Doses of Cannabidiol (CBD) on Heart Rate (HR) Corrected QT Interval (QTc) in Healthy Adults

Trial Profile

A Randomized, Double-blind, Placebo (PBO) and Positive-Controlled Four-way Crossover Study Assess the Effects of Single Therapeutic and Supratherapeutic Doses of Cannabidiol (CBD) on Heart Rate (HR) Corrected QT Interval (QTc) in Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jan 2018

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Jan 2018 New trial record
    • 05 Dec 2017 Results presented at the 71st Annual Meeting of the American Epilepsy Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top